C Leiendecker‐Foster

Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment

Donna K. Arnett, Barry R. Davis, Charles E. Ford et al. · Circulation · 2005 · 142 citations

Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and <i>HFE</i> Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study

James C. Barton, Ronald T. Acton, Fitzroy W. Dawkins et al. · Genetic Testing · 2005 · 80 citations

Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study

Barry R. Davis, Donna K. Arnett, Eric Boerwinkle et al. · The Pharmacogenomics Journal · 2006 · 47 citations

Hypertension, Cardiovascular Disease, Antihypertensive Therapy +8

Comparison of the Unsaturated Iron-Binding Capacity with Transferrin Saturation as a Screening Test to Detect C282Y Homozygotes for Hemochromatosis in 101 168 Participants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study

Paul C. Adams, David M. Reboussin, C Leiendecker‐Foster et al. · Clinical Chemistry · 2005 · 39 citations · Full text

Genetic Testing, Genetics, Pathology +19

Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

James C. Barton, Snively Bm, P C Adams et al. · PubMed · 2006 · 39 citations